FDA seeking to stop procedures at two unregulated stem cell clinics

The FDA accused the clinics of endangering patient safety and failing to meet manufacturing standards for cell therapies.
Stem cells Source: Spencer Platt/Getty Images

Federal officials moved on Wednesday to stop two clinics from continuing to offer unproven stem cell therapies to patients, the most aggressive action taken in years by regulators against the burgeoning — and what critics call dangerous — field of unapproved, direct-to-consumer stem cell treatments.

In seeking permanent injunctions against the clinics, the Justice Department and the Food and Drug Administration accused the clinics of endangering patient safety and failing around the country and have typically steered clear of regulations by insisting their treatments do not fall under the category of drugs.

Citiți o mostră, înregistrați-vă pentru a citi în continuare.

Mai multe de la STAT

STAT1 min cititeBiology
STAT+: Pharmalittle: Pfizer-BioNTech Vaccine Seems To Work Against Covid-19 Mutation; Sarepta Gene Therapy Shows Mixed Results
United Kingdom regulators cleared the Moderna Covid-19 vaccine, adding a third shot for emergency use against the pandemic as infections surge there.
STAT1 min cititeAmerican Government
STAT+: Pharmalittle: Biden Taps Kessler To Lead Operation Warp Speed; Trump Administration Seeks Term Limits On Top FDA, CDC Scientists
President-elect Joe Biden has chosen David Kessler to help lead Operation Warp Speed, the program to accelerate development of Covid-19 vaccines and treatments.
STAT1 min cititeMedical
STAT+: Pharmalittle: Pfizer And BioNTech Say Vaccine Is Effective Against Covid-19 Variant; U.S. To Join COVAX Initiative
The Pfizer-BioNTech Covid-19 vaccine appears to work just as well against a fast-spreading variant first identified in the U.K. as it does against earlier forms of the coronavirus.